Abstract
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have